Comment on: Boden et al. (2007) combined use of rosiglitazone and fenofibrate in patients with type 2 diabetes: Prevention of fluid retention: Diabetes 56:248-255 [1]

Research output: Contribution to journalLetter

Original languageEnglish
JournalDiabetes
Volume56
Issue number5
DOIs
StatePublished - 1 May 2007

Fingerprint

rosiglitazone
Fenofibrate
Hypolipidemic Agents
Thiazolidinediones
Combination Drug Therapy
Hypoglycemic Agents
Type 2 Diabetes Mellitus
Edema

Cite this

@article{455e4361868c429abe74da1d4f47f46e,
title = "Comment on: Boden et al. (2007) combined use of rosiglitazone and fenofibrate in patients with type 2 diabetes: Prevention of fluid retention: Diabetes 56:248-255 [1]",
author = "Jeffrey Stroup",
year = "2007",
month = "5",
day = "1",
doi = "10.2337/db07-0082",
language = "English",
volume = "56",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "5",

}

TY - JOUR

T1 - Comment on

T2 - Boden et al. (2007) combined use of rosiglitazone and fenofibrate in patients with type 2 diabetes: Prevention of fluid retention: Diabetes 56:248-255 [1]

AU - Stroup, Jeffrey

PY - 2007/5/1

Y1 - 2007/5/1

UR - http://www.scopus.com/inward/record.url?scp=34248212236&partnerID=8YFLogxK

U2 - 10.2337/db07-0082

DO - 10.2337/db07-0082

M3 - Letter

C2 - 17470558

AN - SCOPUS:34248212236

VL - 56

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 5

ER -